Bahrain vs Northern Europe: Proportion of the target population who received a 3rd dose of
Bahrain
99.0%
in 2024
Northern Europe
89.0%
in 2024
Bahrain rank
1st
Northern Europe rank
2nd
Proportion of the target population who received a 3rd dose of over time
- Bahrain
- Northern Europe
How they compare
Bahrain currently reports 99.0% against 89.0% in Northern Europe, a difference of 10.0%.
That makes Bahrain's figure about 1.1 times Northern Europe's.
Across all 17 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 1st and Northern Europe ranks 2nd of 157 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Northern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.0% | 13.5% | 41.5% | Bahrain |
| 2010s | 98.3% | 89.1% | 9.2% | Bahrain |
| 2020s | 98.8% | 89.4% | 9.4% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bahrain or Northern Europe?
- Bahrain, at 99.0% against 89.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bahrain and Northern Europe?
- 10.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Northern Europe?
- 17 years are reported by both, from 2008 to 2024.
- How do Bahrain and Northern Europe rank globally for proportion of the target population who received a 3rd dose of?
- Bahrain ranks 1st and Northern Europe ranks 2nd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.